| 000 | 01669 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250513224842.0 | ||
| 264 | 0 | _c20001222 | |
| 008 | 200012s 0 0 eng d | ||
| 022 | _a0013-7227 | ||
| 024 | 7 |
_a10.1210/endo.141.12.7803 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOmerovic, E | |
| 245 | 0 | 0 |
_aGrowth hormone improves bioenergetics and decreases catecholamines in postinfarct rat hearts. _h[electronic resource] |
| 260 |
_bEndocrinology _cDec 2000 |
||
| 300 |
_a4592-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBody Weight |
| 650 | 0 | 4 |
_aCatecholamines _xmetabolism |
| 650 | 0 | 4 |
_aDopamine _xanalysis |
| 650 | 0 | 4 | _aEchocardiography, Doppler |
| 650 | 0 | 4 | _aEnergy Metabolism |
| 650 | 0 | 4 |
_aEpinephrine _xanalysis |
| 650 | 0 | 4 | _aHemodynamics |
| 650 | 0 | 4 |
_aHuman Growth Hormone _xblood |
| 650 | 0 | 4 |
_aInsulin-Like Growth Factor I _xanalysis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMyocardial Infarction _xdrug therapy |
| 650 | 0 | 4 |
_aMyocardium _xchemistry |
| 650 | 0 | 4 |
_aNatriuretic Peptide, Brain _xblood |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReceptors, Adrenergic, beta _xanalysis |
| 650 | 0 | 4 | _aVentricular Function, Left |
| 700 | 1 | _aBollano, E | |
| 700 | 1 | _aMobini, R | |
| 700 | 1 | _aKujacic, V | |
| 700 | 1 | _aMadhu, B | |
| 700 | 1 | _aSoussi, B | |
| 700 | 1 | _aFu, M | |
| 700 | 1 | _aHjalmarson, A | |
| 700 | 1 | _aWaagstein, F | |
| 700 | 1 | _aIsgaard, J | |
| 773 | 0 |
_tEndocrinology _gvol. 141 _gno. 12 _gp. 4592-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1210/endo.141.12.7803 _zAvailable from publisher's website |
| 999 |
_c11049568 _d11049568 |
||